ATLAS / Macro Radar / Reporting / BOLD

Boundless Bio, Inc. (BOLD) reporting calendar

Boundless Bio, Inc. files periodic reports with the SEC as BOLD on Nasdaq. Atlas tracks 9 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
13 Jul 2026 – 1 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
8 May 2026
Reports on record
9

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open BOLD market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20268 May 202638 days0001193125-26-213321
10-K31 Dec 20259 Mar 202668 days0001193125-26-097543
10-Q30 Sep 20255 Nov 202536 days0001193125-25-265714
10-Q30 Jun 20255 Aug 202536 days0000950170-25-102391
10-Q31 Mar 20259 May 202539 days0000950170-25-067496
10-K31 Dec 202427 Mar 202586 days0000950170-25-045725
10-Q30 Sep 20247 Nov 202438 days0000950170-24-123291
10-Q30 Jun 202412 Aug 202443 days0000950170-24-095421
10-Q31 Mar 202413 May 202443 days0000950170-24-058188

Source: SEC EDGAR company submissions for CIK 0001782303. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.